...
首页> 外文期刊>Bioorganic and medicinal chemistry >Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety
【24h】

Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety

机译:碳酸酐酶抑制剂:掺有4,5,6,7-四氯邻苯二甲酰亚胺基团的苯磺酰胺合成和抑制胞质哺乳动物碳酸酐酶同工型I,II和VII

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 4,5,6,7-tetrachloro-1,3-dioxoisoindolin-2-yl benzenesulfonamide derivatives (compounds 1-8) was synthesized by reaction of benzene sulfonamides incorporating primary amino moieties with 4,5,6,7-tetrachlorophthalic anhydride. These sulfonamides were assayed as inhibitors of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1). Some of these compounds showed very good in vitro human carbonic anhydrase (hCA) isoforms I, II and VII inhibitory properties, with affinities in the low nanomolar range. Inhibition activities against hCA I were in the range of 159-444 nM; against hCA II in the range of 2.4-4515 nM, and against hCA VII in the range of 1.3-469 nM. The structure-activity relationship (SAR) with this series of sulfonamides is straightforward, with the main features leading to good activity for each isoform being established.
机译:通过结合伯氨基部分的苯磺酰胺与4,5,6,7-的反应,合成了一系列4,5,6,7-四氯-1,3-二氧异吲哚-2-基苯磺酰胺衍生物(化合物1-8)。四氯邻苯二甲酸酐。这些磺酰胺被测定为金属酶碳酸酐酶的抑制剂(CA,EC 4.2.1.1)。这些化合物中的某些显示出非常好的体外人碳酸酐酶(hCA)同工型I,II和VII抑制特性,亲和力在低纳摩尔范围内。对hCA I的抑制活性为159-444 nM;针对hCA II的范围为2.4-4515 nM,针对hCA VII的范围为1.3-469 nM。该系列磺酰胺的结构活性关系(SAR)很简单,其主要特征是可以为每种同工型建立良好的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号